Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Potassium chloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sando-K effervescent tablets
0902011U0BIAAAF
|
Sando-K | Potassium chloride | Nutrition and Blood | 25,045 |
|
Pot chloride 600mg / Pot bicarb 400mg (12mmol) efferv tab
0902011U0AAAFAF
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 6,144 |
|
Potassium chloride 600mg (potassium 8mmol) MR tab
0902011U0AAAHAH
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 1,794 |
|
Kay-Cee-L syrup
0902011U0BBABAB
|
Kay-Cee-L | Potassium chloride | Nutrition and Blood | 1,030 |
|
Potassium chloride 375mg/5ml (potassium 5mmol/5ml) soln SF
0902011U0AAABAB
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 720 |
|
PotaChlor 600mg (8mmol) modified-release tablets
0902011U0BPAAAH
|
PotaChlor | Potassium chloride | Nutrition and Blood | 310 |
|
Aad K 600mg (8mmol) Slow Release tablets
0902011U0BQAAAH
|
Aad K | Potassium chloride | Nutrition and Blood | 63 |
|
Potassium chloride 375mg/5ml oral solution
0902011U0AAARAR
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 28 |
|
Potassium chloride 750mg/5ml oral solution
0902011U0AAASAS
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 14 |
|
Slow-K 600mg tablets
0902011U0BGAAAH
|
Slow-K | Potassium chloride | Nutrition and Blood | 9 |
|
Potassium chloride 1g/5ml oral solution
0902011U0AAAYAY
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 2 |
|
Potassium chloride 600mg (potassium 8mmol) MR caps
0902011U0AABJBJ
|
Potassium chloride (Systemic) | Potassium chloride | Nutrition and Blood | 2 |
|
Pot chlor 0.3% (pot 20mmol/500ml)/Sod chlor 0.9% inf 500ml
0902021N0AAARAR
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | 1 |
|
AabKCL effervescent tablets
0902011U0BSAABK
|
AabKCL | Potassium chloride | Nutrition and Blood | No data available |
|
Aace K effervescent tablets
0902011U0BRAABK
|
Aace K | Potassium chloride | Nutrition and Blood | No data available |
|
Duro-K 600mg tablets
0902011U0BMAAAH
|
Duro-K | Potassium chloride | Nutrition and Blood | No data available |
|
Intraven pot chlor 10mmol/500ml/gluc 5%/NaCl 0.45% inf 500ml
0902021N0BGAABI
|
Intraven potassium chloride | Potassium chloride | Nutrition and Blood | No data available |
|
Kaleorid LP 600mg tablets
0902011U0BNAAAH
|
Kaleorid LP | Potassium chloride | Nutrition and Blood | No data available |
|
Kloref 500mg effervescent tablets
0902011U0BHAAAJ
|
Kloref | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.15% (pot 10mmol/500ml)/Glucose 5% inf 500ml bags
0902021N0AAAWAW
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.15% (pot 10mmol/500ml)/Sod chlor 0.9% inf 500ml
0902021N0AAAVAV
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.15% (pot 20mmol/1L)/Glucose 5% inf 1L bags
0902021N0AAAMAM
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.15% (pot 20mmol/1L)/Glucose 5% inf 1L Viaflex
0902021N0BDADAM
|
Baxter potassium chloride | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.15%(pot 20mmol/1L)/Sod chlor 0.9% inf 1L bags
0902021N0AAAKAK
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | No data available |
|
Pot chlor 0.2% (pot 13.3mmol/500ml)/Glucose 5% inf 500ml
0902021N0AAAYAY
|
Potassium chloride (Parenteral) | Potassium chloride | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.